Literature DB >> 8219655

Systemic vasculitis positive for circulating anti-neutrophil cytoplasmic antibodies and with predominantly neurological presentation.

M Stumvoll1, G Schnauder, D Overkamp, U W Buettner, W Grodd, M Eggstein.   

Abstract

A 57-year-old male patient suffering from dramatically deteriorating diffuse and focal central nervous system symptoms was admitted to hospital after a short prodromal period in a somnolent state. He was diagnosed as having systemic vasculitis positive for circulating anti-neutrophil cytoplasmic antibodies, primarily involving the brain, but also most other organ systems. Circulating anti-neutrophil cytoplasmic antibodies are highly specific for Wegener granulomatosis, though they have been detected in rare cases of other vasculitic syndromes. Central nervous system lesions as presenting signs in Wegener granulomatosis have to be regarded as rare. This case nonetheless suggests that Wegener granulomatosis has to be considered in patients with a predominantly cerebral manifestation of a vasculitic syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219655     DOI: 10.1007/bf00184485

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  9 in total

1.  [The magnetic resonance tomographic signs of Wegener's granulomatosis in the head area].

Authors:  R Asmus; C Muhle; H Koltze; R P Spielmann; W L Gross; G Duncker; B Nölle; A Beigel
Journal:  Rofo       Date:  1992-07

2.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

3.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

4.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

5.  Neurological complications of vasculitis.

Authors:  P M Moore; T R Cupps
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

6.  Wegener granulomatosis: an analysis of 158 patients.

Authors:  G S Hoffman; G S Kerr; R Y Leavitt; C W Hallahan; R S Lebovics; W D Travis; M Rottem; A S Fauci
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

Review 7.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

8.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

Review 9.  Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.

Authors:  J C Jennette; R J Falk
Journal:  Am J Kidney Dis       Date:  1990-06       Impact factor: 8.860

  9 in total
  2 in total

1.  MR Imaging in Wegener granulomatosis of the spinal cord.

Authors:  Hans-J Mentzel; Thomas Neumann; Clemens Fitzek; Dieter Sauner; Jürgen R Reichenbach; Werner A Kaiser
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

2.  The upper thoracic spinal cord compression as the initial manifestation of Wegener's granulomatosis: a case report.

Authors:  De-Chun Wang; Jian-Wei Wei; Ji-Hua Liu; You-Gu Hu
Journal:  Eur Spine J       Date:  2007-02-09       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.